Email
Print
1. Executive Summary
1.1. Executive Summary – 1: Covid-19 Japan Overall Cases Report (2020-2022)
1.2. Executive Summary – 2: Covid-19 Japan Overall Vaccine Report (2021-2022)
2. Covid-19 Cases and Deaths in Japan (2020-2022)
2.1. Total Number of Covid-19 Confirmed Cases (Millions) in Japan 2020
2.2. Total Number of Covid-19 Confirmed Cases Growth Rate (%) in Japan 2020
2.3. Total Number of Covid-19 Confirmed Cases (Millions) in Japan 2021-2022
2.4. Total Number of Covid-19 Confirmed Cases Growth Rate (%) in Japan 2021-2022
2.5. Total Number of Covid-19 Cases Prevalence Rate (%) in Japan 2020-2022
2.6. Covid-19 Male Mortality by Age in Japan -2020
2.7. Covid-19 Female Mortality by Age in Japan-2020
2.8. Covid-19 Male Mortality by Age (Thousands) in Japan -2021
2.9. Covid-19 Female Mortality by Age (Thousands) In Japan -2021
2.10. Covid-19 Mortality by Age (Thousands) in Japan -2022
2.11. Total Number of Covid-19 Reported Deaths (Thousands) in Japan -2020
2.12. Total Number of Covid-19 Death Cases Growth Rate (%) in Japan -2020
2.13. Total Number of Covid-19 Reported Deaths (Thousands) in Japan - (2021-2022)
2.14. Total Number of Covid-19 Death Cases Growth Rate (%) in Japan- (2021-2022)
2.15. Total Number of Covid-19 Confirmed Cases and Death Cases in (Millions) Japan (2020-2022)
2.16. Major Comorbidity Conditions Contributing to Covid-19 Deaths in Japan 2019-2022
2.17. Major Comorbidity Conditions Growth rate (%) Contributing to Covid-19 Deaths in Japan 2019-2022
2.18. Fatality Rate of Covid-19 in Percentage (%) in Japan 2020
2.19. Fatality Rate of Covid-19 in Percentage (%) in Japan (2021-2022)
3. Covid-19 Vaccine Production in Japan (2021-2022)
3.1. Total No. of Covid-19 Vaccine Cumulative Production in Japan (Million Doses) 2021
3.2. Total No. of Covid-19 Vaccine Cumulative Production Growth Rate (%) in Japan (Million Doses) 2021
3.3. Total No. of Covid-19 Vaccine Monthly Production in Japan (Million Doses) 2021
3.4. Total No. of Covid-19 Vaccine Monthly Production Growth Rate (%) in Japan 2021
3.5. Covid-19 vaccination coverage in Japan (2021-2022)
3.6. Covid-19 At least One Dose Vaccination Details (Millions) in Japan (2021-2022)
3.7. Covid-19 Fully Vaccinated Doses (Millions) in Japan (2021-2022)
3.8. Covid-19 Booster Dose Count (Millions) in Japan (2021-2022)
3.9. Percentage of Covid-19 Vaccination-Single Dose/Double Dose Vaccination in Japan (2021-2022)
3.10. Percentage of Covid-19 Vaccination Booster Dose in Japan (2021-2022)
4. Trade of Covid-19 Related Products by in Japan (2016-2020)
4.1. Knitted Hair Nets Exports in Japan in Volume (Th Metric Tons) 2016-2020
4.2. Knitted Hair Nets Exports in Japan in Value (US$ Million) 2016-2020
4.3. Knitted Hair Nets Imports in Japan in Volume (Th Metric Tons) 2016-2020
4.4. Knitted Hair Nets Imports in Japan in Value (US$ Million) 2016-2020
4.5. PPE Kits Exports in Japan in Volume (Th Metric Tons) 2016-2020
4.6. PPE Kits Exports in Japan in Value (US$ Million) 2016-2020
4.7. PPE Kits Imports in Japan in Volume (US$ Million) 2016-2020
4.8. PPE Kits Imports in Japan in Value (US$ Million) 2016-2020
4.9. Test Kit Reagents Exports in Japan in Volume (Th Metric Tons) 2016-2020
4.10. Test Kit Reagents Exports in Japan in Value (Th Metric Tons) 2016-2020
4.11. Test Kit Reagents Imports in Japan in Volume (Th Metric Tons) 2016-2020
4.12. Test Kit Reagents Imports in Japan in Value (US$ Million) 2016-2020
4.13. Test Kits Exports in Japan in Volume (Th Metric Tons) 2017-2020
4.14. Test Kits Exports in Japan in Value (US$ Million) 2017-2020
4.15. Test Kits Imports in Japan in Volume (Th Metric Tons) 2017-2020
4.16. Test Kits Imports in Japan in Value (US$ Million) 2017-2020
4.17. Surgical Gloves Imports in Japan in Volume 2016-2020
4.18. Surgical Gloves Imports in Japan in Value (US$ Million) 2016-2020
4.19. Major Recipients of Japan Covid-19 Vaccine Donation in Million Deliveries by Total Doses Received
4.20. Japan Covid-19 Vaccine Donation in Million Deliveries by Region
5. Covid-19: Research Approaches in Japan (2020-2022)
5.1. No. of Clinical trials of Covid-19 in Japan (2019-2022)
5.2. No. of Clinical trials of Covid-19 Japan in Phases (2019-2022)
5.3. Percentage of Clinical trials of Covid-19 Japan by Age (2019-2022)
5.4. No. of Clinical trials of Covid-19 Japan by Funding Type (2019-2022)
5.5. No. of Clinical trials of Covid-19 Japan by Status (2019-2022)
5.6. No. of Clinical trials of Covid-19 Japan by Study Type (2019-2022)
5.7. No. of Clinical trials of Covid-19 Japan by Study Documents (2019-2022)
5.8. Total No. of Covid-19 Patents Documented in Japan 2021
5.9. Total No. of Covid-19 Patent Documents by Published, Filed and Granted Date in Japan 2021
5.10. Total No. of Covid-19 Patent documents by Type in Japan by Study 2021
5.11. Total No. of Covid-19 Patents Legal Status in Japan 2021
5.12. Total No. of Major Applicants of Covid-19 in Japan 2021
5.13. Major 10 Covid-19 Study Institution Name by Document Type in Japan 2020
5.14. Major 10 Covid-19 Study Institution Name by Document Type in Japan 2021
5.15. Major 5 Fields of Covid-19 Study Covered by The Most Active Institutions in Japan 2020
5.16. Major 5 Fields of Covid-19 Study Covered by The Most Active Institutions in Japan 2021
6. Government of Japan Funding on Covid-19 (2020-2022)
6.1. Japan Government Funding Amount for Covid-19 Vaccine & therapeutics in Million USD (2020-2022)
6.2. Real GDP Contributing Sectors in Japan (In Trillion USD)
6.3. Real GDP Contributing Sectors in Japan in Percentage (%)
6.4. Real GDP Contribution (%) of Manufacturing Sector in Japan
6.5. Real GDP Contribution (%) of Agriculture Sector in Japan
6.6. Real GDP Contribution (%) of Construction Sector in Japan
6.7. Real GDP Contribution (%) of Other Sectors in Japan
7. Covid-19 Key Trends in Japan
8. Research Methodology
9. Disclaimer